TREATMENT OF CORONAVIRUS INFECTION
    7.
    发明申请
    TREATMENT OF CORONAVIRUS INFECTION 失效
    治疗冠状病毒感染

    公开(公告)号:US20090149545A1

    公开(公告)日:2009-06-11

    申请号:US10856281

    申请日:2004-05-28

    IPC分类号: A61K31/166 A61P31/12

    CPC分类号: A61K31/33

    摘要: A method for treating coronavirus infection by administering to a subject in need of the treatment an effective amount of one or more of the following compounds: aklavin, sanguinarine, amiodarone, chlorpromazine, clomiphene, dihydroergotamine, dipyridamole, emetine, ephedrine, prochlorperazine, promazine, propiomazine, aminacrine, fluphenazine, fenoterol, peruvoside, proglumide, atenolol, nerifolin, nefopam, cycloheximide, avermectin B1, bepridil, cinnarizine, ethisterone, pararosaniline, methylbenzethonium, niclosamide, pipobroman, homidium, calcimycin, anisomycin, metergoline, amodiaquine, danazol, danthron, ethopropazine, eucatropine, nortriptyline, resorcinol, mebhydrolin, mebeverine, trimipramine, triflupromazine, chlorprothixene, cyclobenzaprine, enoxacin, sulfanitran, monensin, nigericin, perphenazine, methoxamine, astemizole, trifluoperazine, acriflavinium, rotenone, acebutolol, quabain, methiothepin, convallatoxin, halcinonide, cyclosporin, pimethixene, mycophenolic acid, promethazine, mesoridazine, thioridazine, chlorprothixene, thiothixene, clozapine, haloperidol, haloperidol decanoate, loxapine, molindone, olanzapine, pimozide, quetiapine, risperidone, and amitriptyline.

    摘要翻译: 一种通过向需要治疗的受试者施用有效量的一种或多种以下化合物来治疗冠状病毒感染的方法:阿伐黄素,血根碱,胺碘酮,氯丙嗪,克罗米酚,二氢麦角胺,双嘧达莫,埃米汀,麻黄素,丙氯拉嗪, 丙诺霉素,氨基吖啶,氟奋乃静,非诺替尔,紫苏碱,恩替洛尔,阿替洛尔,奈非泮,奈非泮,放线菌酮,阿维菌素B1,苯普利,桂酸,乙胺,对羟基苯胺,甲基苄索铵,氯硝柳胺,pipobroman,homidium,calcimycin,茴香霉素,metergoline,amodiaquine,达那唑, 依托泊汀,间苯二酚,替康罗林,美勃司宁,间苯丙胺,三氟丙嗪,氯替噻吩,环苯扎林,依诺沙星,磺胺三苯胺,莫能菌素,尼日利亚,奋乃静,甲氧胺,阿司咪唑,三氟拉嗪,吖啶鎓,鱼藤酮, ,环孢菌素,哌甲酯,霉酚酸, 乙氮嗪,美索达嗪,硫利达嗪,氯普ix辛,硫代四氢噻吩,氯氮平,氟哌啶醇,氟哌啶醇癸酸酯,洛沙平,莫洛多内,奥氮平,匹莫齐特,喹硫平,利培酮和阿米替林。

    Treatment of coronavirus infection
    10.
    发明授权
    Treatment of coronavirus infection 失效
    冠状病毒感染的治疗

    公开(公告)号:US07544712B1

    公开(公告)日:2009-06-09

    申请号:US10856281

    申请日:2004-05-28

    IPC分类号: A61K31/33 A01N47/10

    CPC分类号: A61K31/33

    摘要: A method for treating coronavirus infection by administering to a subject in need of the treatment an effective amount of one or more of the following compounds: aklavin, sanguinarine, amiodarone, chlorpromazine, clomiphene, dihydroergotamine, dipyridamole, emetine, ephedrine, prochlorperazine, promazine, propiomazine, aminacrine, fluphenazine, fenoterol, peruvoside, proglumide, atenolol, nerifolin, nefopam, cycloheximide, avermectin B1, bepridil, cinnarizine, ethisterone, pararosaniline, methylbenzethonium, niclosamide, pipobroman, homidium, calcimycin, anisomycin, metergoline, amodiaquine, danazol, danthron, ethopropazine, eucatropine, nortriptyline, resorcinol, mebhydrolin, mebeverine, trimipramine, triflupromazine, chlorprothixene, cyclobenzaprine, enoxacin, sulfanitran, monensin, nigericin, perphenazine, methoxamine, astemizole, trifluoperazine, acriflavinium, rotenone, acebutolol, quabain, methiothepin, convallatoxin, halcinonide, cyclosporin, pimethixene, mycophenolic acid, promethazine, mesoridazine, thioridazine, chlorprothixene, thiothixene, clozapine, haloperidol, haloperidol decanoate, loxapine, molindone, olanzapine, pimozide, quetiapine, risperidone, and amitriptyline.

    摘要翻译: 一种通过向需要治疗的受试者施用有效量的一种或多种以下化合物来治疗冠状病毒感染的方法:阿伐黄素,血根碱,胺碘酮,氯丙嗪,克罗米酚,二氢麦角胺,双嘧达莫,埃米汀,麻黄素,丙氯拉嗪, 丙诺霉素,氨基吖啶,氟奋乃静,非诺替尔,紫苏碱,恩替洛尔,阿替洛尔,奈非泮,奈非泮,放线菌酮,阿维菌素B1,苯普利,桂酸,乙胺,对羟基苯胺,甲基苄索铵,氯硝柳胺,pipobroman,homidium,calcimycin,茴香霉素,metergoline,amodiaquine,达那唑, 依托泊汀,间苯二酚,替康罗林,美勃司宁,间苯丙胺,三氟丙嗪,氯替噻吩,环苯扎林,依诺沙星,磺胺三苯胺,莫能菌素,尼日利亚,奋乃静,甲氧胺,阿司咪唑,三氟拉嗪,吖啶鎓,鱼藤酮, ,环孢菌素,哌甲酯,霉酚酸, 乙氮嗪,美索达嗪,硫利达嗪,氯普ix辛,硫代四氢噻吩,氯氮平,氟哌啶醇,氟哌啶醇癸酸酯,洛沙平,莫洛多内,奥氮平,匹莫齐特,喹硫平,利培酮和阿米替林。